RMIDATAHUB.ORG

As part of the RMIP, the Regenerative Medicine Innovation Catalyst (RMIC) is a resource that is funded by NIH to drive the efficient development of safe and effective adult stem cell-based therapies and to further the field of regenerative medicine. The RMIC offers services and resources to investigators to facilitate the conduct of their studies. Ultimately, the activities of the RMIC will allow a deeper understanding of stem cell clinical products, in part by facilitating the correlation of cell characterization with clinical outcomes data.